Table 2.
Dysbiotic patterns, an increased Firmicutes/Bacteroidetes ratio and decreased abundance of short chain fatty acid producing bacteria, have been linked to various effects on systemic inflammation and cardiometabolic health.
Gut microbiome imbalance | Effect on systemic inflammation and cardiometabolic health |
---|---|
↑ F/B ratio | -Associated with an increase in proatherogenic TMAO production -Linked to obesity and insulin resistance in several studies -Observed in heart disease patients and hypertensive mice -Alters carbohydrate metabolism of SCFAs and MCFAs |
↓ SCFA-producing bacteria (includes Faecalibacterium, Akkermansia, Ruminococcus, Bifidobacterium, Lactobacillus, Bacteroides spp., and others) | - Observed in obesity, diabetes, insulin resistance, hypertension, atherosclerosis, coronary artery disease, and carotid artery disease patients -Butyrate, a SCFA, has key anti-inflammatory properties and has been shown to suppress Th17 and induce Treg cell development and expansion -Butyrate reduces appetite and supports glucose homeostasis -SCFAs are key energy sources for intestinal epithelial cells -SCFAs help to maintain intestinal epithelial barrier integrity |
Key: F/B: Firmicutes/Bacteroidetes, SCFA: short-chain fatty acid, MCFA: medium-chain fatty acid, TMAO: Trimethylamine-N-oxide